2021
DOI: 10.1007/978-3-030-70115-4_2
|View full text |Cite|
|
Sign up to set email alerts
|

Mucin-Type O-GalNAc Glycosylation in Health and Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 321 publications
0
15
0
Order By: Relevance
“…Mucins are a large family of high molecular weight proteins, which are composed of amino acids (such as glycine, serine, and threonine) ( Feller et al, 1990 ; Chakraborty et al, 2011 ; Ramsey et al, 2016 ; Bansil and Turner, 2018 ). And, Mucin O-glycosylation is a common covalent modification of serine and threonine residues of glycoproteins ( Van den Steen et al, 1998 ; Bagdonaite et al, 2021 ). Therefore, our results indicate that heat stress may affect the synthesis of mucins via amino acid metabolic and O-glycan biosynthesis.…”
Section: Discussionmentioning
confidence: 99%
“…Mucins are a large family of high molecular weight proteins, which are composed of amino acids (such as glycine, serine, and threonine) ( Feller et al, 1990 ; Chakraborty et al, 2011 ; Ramsey et al, 2016 ; Bansil and Turner, 2018 ). And, Mucin O-glycosylation is a common covalent modification of serine and threonine residues of glycoproteins ( Van den Steen et al, 1998 ; Bagdonaite et al, 2021 ). Therefore, our results indicate that heat stress may affect the synthesis of mucins via amino acid metabolic and O-glycan biosynthesis.…”
Section: Discussionmentioning
confidence: 99%
“…Regulation of O-glycan initiation by competing GalNAc-Ts is not completely understood, and while there is no consensus sequence for O-glycosylation in general, or the individual isoforms, there are slight differences in amino acid context preference by the individual catalytic domains [42,43].…”
Section: Discussionmentioning
confidence: 99%
“…Regulation of O-glycan initiation by competing GalNAc-Ts is not completely understood, and while there is no consensus sequence for O-glycosylation in general, or the individual isoforms, there are slight differences in amino acid context preference by the individual catalytic domains (Bagdonaite et al, 2021; de Las Rivas et al, 2019). Furthermore, most GalNAc-Ts are capable of long-range follow-up due to positioning by the lectin domain recognizing distant already glycosylated sites, where varying linker length between the two domains determines the range (de Las Rivas et al, 2017; Fritz et al, 2004; Pedersen et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…The generalization of these approaches has been greatly facilitated by the pioneer work at Wandall’s lab [ 136 , 138 , 140 , 141 ], which delivered a validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome [ 142 ]. This technology has been used to generate a wide number of different cancer cells expressing immature O -GalNAc glycosylation [ 143 145 ] which, to great extent, support our current knowledge on their role in heath and disease [ 146 ]. However, cellular glycoengineering for modulation of protein N - and O -glycosylation is being explored beyond its functional dimension, constituting an important tool for producing therapeutic glycoproteins [ 147 , 148 ] (Fig.…”
Section: Models For Cancer Glycobiology and Glycoimmunologymentioning
confidence: 99%